These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10643443)

  • 1. The first miracle in neurodegenerative disease: the discovery of oral levodopa.
    Kordower JH; Goetz CG
    Brain Res Bull; 1999; 50(5-6):377-8. PubMed ID: 10643443
    [No Abstract]   [Full Text] [Related]  

  • 2. Levodopa: 50 years of a revolutionary drug for Parkinson disease.
    Fahn S; Poewe W
    Mov Disord; 2015 Jan; 30(1):1-3. PubMed ID: 25488146
    [No Abstract]   [Full Text] [Related]  

  • 3. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract]   [Full Text] [Related]  

  • 5. L-DOPA.
    Hornykiewicz O
    J Parkinsons Dis; 2017; 7(s1):S3-S10. PubMed ID: 28282813
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
    Birkmayer W; Hornykiewicz O
    Wien Klin Wochenschr; 2001 Nov; 113(22):851-4. PubMed ID: 11763859
    [No Abstract]   [Full Text] [Related]  

  • 7. [L-dopa: a fascinating history].
    García de Yébenes J; García Ruiz P
    Neurologia; 1998; 13 Suppl 1():36-40. PubMed ID: 9859684
    [No Abstract]   [Full Text] [Related]  

  • 8. [Madopar: more than 20 years].
    Leiva C
    Rev Neurol; 1997 Dec; 25(148):1957-63. PubMed ID: 9528041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease. A half century of progress.
    Jankovic J
    Neurology; 2001 Nov; 57(10 Suppl 3):S1-3. PubMed ID: 11771154
    [No Abstract]   [Full Text] [Related]  

  • 10. [Short history of L-Dopa].
    García Ruiz PJ; Meseguer E
    Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Deleu D; Hanssens Y
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16721952
    [No Abstract]   [Full Text] [Related]  

  • 13. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago.
    Hornykiewicz O
    Wien Klin Wochenschr; 2001 Nov; 113(22):855-62. PubMed ID: 11762121
    [No Abstract]   [Full Text] [Related]  

  • 14. 50 years of levodopa.
    Hornykiewicz O
    Mov Disord; 2015 Jun; 30(7):1008. PubMed ID: 25999218
    [No Abstract]   [Full Text] [Related]  

  • 15. Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s.
    Santos-Lobato BL; Tumas V
    Arq Neuropsiquiatr; 2016 Aug; 74(8):687-9. PubMed ID: 27556381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current possibilities of quality of life improvement in the late stages of Parkinson's disease].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):94-100. PubMed ID: 26171484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral formulations of L-dopa and continuous dopaminergic stimulation.
    Iansek R; Danoudis M
    Mov Disord; 2012 Apr; 27(4):579. PubMed ID: 22344707
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply: Oleh Hornykiewicz's contribution to the l-dopa story.
    Fahn S
    Mov Disord; 2015 Jun; 30(7):1008-9. PubMed ID: 25880230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
    Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):21-4. PubMed ID: 14681961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of levodopa and dopamine agonists in Parkinson's disease treatment.
    Tolosa E; Martí MJ; Valldeoriola F; Molinuevo JL
    Neurology; 1998 Jun; 50(6 Suppl 6):S2-10; discussion S44-8. PubMed ID: 9633679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.